One hundred one consecutive patients with chronic coronary artery disease who had survived out-of-hospital cardiac arrest in the absence of acute myocardial infarction underwent electrophysiologic evaluation and were followed prospectively. Ventricular tachyarrhythmias were inducible in 76 patients (75%) in the control state and were suppressed by antiarrhythmic drugs or surgery in 32 of the 76 patients (42%). During a mean follow-up of 27 months, cardiac arrest recurred in 21 patients: in two of the 25 patients in whom ventricular tachyarrhythmias were not inducible in the control state, three of the 32 in whom inducible ventricular tachyarrhythmias were suppressed after treatment, and 16 of the 44 in whom inducible ventricular tachyarrhythmias could not be suppressed after treatment. Actuarial rate of cardiac arrest recurrence was 11.2% during the first 6 months of follow-up ("high-risk early phase") and then decreased to less than 4% in each subsequent 6-month period. Multivariate Cox proportional hazards analysis identified an ejection fraction less than 35% (p=0.0013) and persistent inducibility of ventricular tachyarrhythmias (p=0.0025) as independent predictors of cardiac arrest recurrence for the entire follow-up period. Separate analysis of variables within and after the first 6 months showed that an ejection fraction less than 35% was the strongest predictor for early phase recurrence (p=0.0078) but had only marginally significant predictive value for late phase recurrence (p =0.0516). Persistent inducibility of ventricular tachyarrhythmias had no significant predictive value for early phase recurrence (p=0.1382) but was the strongest predictor for late phase recurrence (p=0.0061). These data suggest that, in patients with chronic coronary artery disease who survive out-of-hospital cardiac arrest, poor ejection fraction and persistent inducibility of ventricular tachyarrhythmias have a different predictive influence on early and late phase recurrence. Time-dependent risk factor analysis may have great clinical relevance in assessing an individual's changing risk over time. (Circulation 1989;80:599-608 One hundred forty-two consecutive patients who had survived out-of-hospital cardiac arrest unassociated with a myocardial infarction within the three weeks preceding the arrest underwent electrophys-
One hundred one consecutive patients with chronic coronary artery disease who had survived out-of-hospital cardiac arrest in the absence of acute myocardial infarction underwent electrophysiologic evaluation and were followed prospectively. Ventricular tachyarrhythmias were inducible in 76 patients (75%) in the control state and were suppressed by antiarrhythmic drugs or surgery in 32 of the 76 patients (42%). During a mean follow-up of 27 months, cardiac arrest recurred in 21 patients: in two of the 25 patients in whom ventricular tachyarrhythmias were not inducible in the control state, three of the 32 in whom inducible ventricular tachyarrhythmias were suppressed after treatment, and 16 of the 44 in whom inducible ventricular tachyarrhythmias could not be suppressed after treatment. Actuarial rate of cardiac arrest recurrence was 11.2% during the first 6 months of follow-up ("high-risk early phase") and then decreased to less than 4% in each subsequent 6-month period. Multivariate Cox proportional hazards analysis identified an ejection fraction less than 35% (p=0.0013) and persistent inducibility of ventricular tachyarrhythmias (p=0.0025) as independent predictors of cardiac arrest recurrence for the entire follow-up period. Separate analysis of variables within and after the first 6 months showed that an ejection fraction less than 35% was the strongest predictor for early phase recurrence (p=0.0078) but had only marginally significant predictive value for late phase recurrence (p =0.0516). Persistent inducibility of ventricular tachyarrhythmias had no significant predictive value for early phase recurrence (p=0.1382) but was the strongest predictor for late phase recurrence (p=0.0061). These data suggest that, in patients with chronic coronary artery disease who survive out-of-hospital cardiac arrest, poor Therapy was assessed by electrophysiologic testing in all patients in whom ventricular tachyarrhythmias were induced in the control state. Evaluated therapies included antiarrhythmic drugs and surgery (endocardial resection, endocardial cryoablation, or aneurysmectomy) guided by electrical mapping of activation sequence. Selection of drug regimens was based on each patient's history of drug tolerance and clinical response. The following drugs were tested after intravenous administration: 10-15 mg/kg (50 mg/min) procainamide, 10 mg/kg (20 mg/min) quinidine, 0.2 mg/kg (1 mg/min) propranolol, and lidocaine, bolus infusion of 225 mg during 20 minutes, followed by a 2-mg/min continuous infusion. The following oral agents were tested at trough blood levels after administration of a sufficient number of doses to attain a steady-state serum drug level: 3-8 g/day procainamide, 1.2-1.6 g/day quinidine, 400-600 mg/day disopyramide, 0.8-1.2 g/day tocainide, 300-600 mg/day mexiletine, 200-400 mg/day flecainide, 140-200 mg/day encainide, and amiodarone 1,200-1,600 mg/day for 10 days, then 600-800 mg/day. Plasma drug concentrations, if available, were measured at the end of each drug study. In four patients, treatment with an oral antiarrhythmic drug was prematurely terminated before electrophysiologic testing because of development of spontaneous sustained ventricular tachycardia (two patients) or incessant ventricular tachycardia (two patients); two with 400 mg/day flecainide, one with procainamide 6 g/day, and one with 140 mg/day encainide. Recommendations for surgical treatment were based on the presence of an apparent discrete left ventricular aneurysm, repro- (Table  3) . Four patients underwent coronary artery bypass grafting in addition to antiarrhythmic surgery. These 32 patients were discharged on the regimen that successfully suppressed induction of ventricular tachyarrhythmias.
Forty patients in whom inducible ventricular tachyarrhythmias persisted after treatment before June 1986 were discharged on a drug regimen in which the induced ventricular tachyarrhythmia was slowed and was associated with hemodynamic stability: five patients with conventional antiarrhythmic drugs, 33 with amiodarone, and two with antiarrhythmic surgery and drugs. Four patients with persistent inducibility of ventricular tachyarrhythmias after June 1986 were treated with the automatic implantable cardioverter-defibrillator with no additional antiarrhythmic drug therapy. Two patients underwent coronary artery bypass grafting in addition to antiarrhythmic surgery, and three underwent coronary artery bypass grafting in addition to implantation of an automatic implantable cardioverterdefibrillator.
The 24 patients without inducible ventricular tachyarrhythmias in the control state were treated as follows: six with conventional antiarrhythmic drugs, five with coronary artery bypass grafting, eight with P-blocking agents, two with antiarrhythmic drugs and coronary bypass grafting, and three with antiarrhythmic drugs and /3-blocking agents.
The clinical characteristics of each of the three subgroups of ventricular tachyarrhythmia inducibility are presented in Table 4 . The subgroup with inducible ventricular tachyarrhythmias that were suppressed after treatment was more likely to have presented with ventricular tachycardia at the time of cardiac arrest than the subgroup without inducible ventricular tachyarrhythmias. Both of the two subgroups with inducible ventricular tachyarrhythmias were significantly more likely to have previous myocardial infarction, left ventricular aneurysm, and lower left ventricular ejection fraction than the subgroup without inducible ventricular tachyarrhythmias. There was no significant difference in any of the clinical characteristics between the two subgroups with inducible ventricular tachyarrhythmias.
Recurrent Cardiac Arrest for the Entire Follow-up Period
During a mean follow-up of 27 months, cardiac arrest recurred in 21 of the 101 patients. In 18 patients resuscitation was not performed or was not successful. Two patients were successfully resuscitated from cardiac arrest, and one had syncope followed by discharge of an implanted cardioverterdefibrillator. The cumulative actuarial rate of cardiac arrest recurrence at 4 years was 24.4+4.8% (Figure 1 ). Recurrent cardiac arrest occurred in two of the 25 without inducible ventricular tachyarrhythmias in the control state, in three of the 32 with inducible ventricular tachyarrhythmias in the control state that were suppressed after treatment, and in 16 of the 44 with inducible ventricular tachyarrhythmias in the control state that could not be suppressed after treatment. Patients with inducible ventricular tachyarrhythmias in the control state that could not be suppressed after treatment had a 40.9±8.0% cumulative cardiac arrest recurrence rate at 4 years. This was significantly higher than the recurrence rate for patients without induc- (Figure 1 ). The actuarial recurrence rate was 11.2% during the first 6 months ("high risk early phase") and then decreased to less than 4% for each subsequent 6-month period. Multivariate Cox proportional hazards analysis was separately applied to the high risk early phase (.6 months) and the lower risk subsequent phase (>6 months) ( The actuarial rate of cardiac arrest recurrence was about the same between patients with no inducible ventricular tachyarrhythmias in the control state (9.0+6.1%) and those in whom inducible ventricular tachyarrhythmias were suppressed after treatment (9.5-+±5.2%).
The group with both a reduced ejection fraction and persistent inducibility of ventricular tachyarrhythmias had a very high recurrence rate over the entire follow-up period irrespective of treatment with antiarrhythmic drugs or surgery. The group with a reduced ejection fraction and no persistent inducibility also had a high recurrence rate during the first 6 months. It is important to identify patients at high risk for recurrence of cardiac arrest in whom aggressive treatment, including the automatic implantable cardioverter-defibrillator, is clearly indicated. Study of the changing time dependence of various predictors for cardiac arrest recurrence can allow an ongoing assessment of risk on an individual basis.
Limitations
Because of the high recurrence of out-of-hospital cardiac arrest, we used a relatively aggressive stimulation protocol of up to four extrastimuli to minimize false-negative responses. This could have yielded some false-positive responses. 30, 31 Long-term therapy was not completely uniform in patients with persistent inducibility of ventricular tachyarrhythmias and in those without inducible ventricular tachyarrhythmias in the control state. These therapeutic biases may limit rigorous interpretation of our results.
The small sample size of various subgroups might have substantially influenced statistical analysis of various predictors, especially those with borderline predictive value.
